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Tissue-resident memory T (TRM) cells
provide efficient protection toward
mucosal infection. Thom et al. show that
murine cytomegalovirus (MCMV) is a
potent inducer of CD8+ and CD4+ TRM
cells in the salivary glands, an important
site of CMV transmission. These findings
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Tissue-residentmemory T cells (TRM) reside in barrier
tissues and provide local immediate protective im-
munity. Here, we show that the salivary gland (SG)
most-effectively induces CD8+ and CD4+ TRM cells
against murine cytomegalovirus (MCMV), which per-
sists in and spreads from this organ. TRM generation
depended on local antigen for CD4+, but not CD8+,
TRM cells, highlighting major differences in T cell
subset-specific demands for TRM development.
CMV-specific CD8+ T cells fail to control virus repli-
cation upon primary infection in the SG due to
CMV-induced MHC I downregulation in glandular
epithelial cells. Using intraglandular infection, we
challenge this notion and demonstrate that memory
CD8+ T cells confer immediate protection against
locally introducedMCMVdespite active viral immune
evasion, owing to early viral tropism to cells that
largely withstand MHC I downregulation. Thus, we
unravel a yet-unappreciated role for memory CD8+
T cells in protecting mucosal tissues against CMV
infection.
INTRODUCTION
Memory T cells are classically divided into central memory
T cells (TCM) and effector memory T cells (TEM) (Sallusto
et al., 1999). TCM cells express CD62L and CCR7, localize
mainly to lymphoid organs, and rapidly expand upon antigen
re-encounter. TEM cells lack CD62L and CCR7 but express
homing molecules that enable them to enter inflamed periph-
eral sites and exert immediate effector functions. Whereas
TEM cells can provide protection against systemic infection,
their ability to contain peripheral infections is surprisingly
limited (Bachmann et al., 2005; Jiang et al., 2012; Mackay
et al., 2012), owing to progressive contraction and loss of
tissue-homing molecules.
Early blood-based studies have established the concept of
circulatory immune surveillance in which memory T cells are in
constant exchangewith either lymphoid or non-lymphoid tissuesCell Repvia the circulation. Recent advances claim for a revision of this
paradigm, as a significant proportion of memory T cells resides
in the periphery without recirculating (Gebhardt et al., 2009;
Hawke et al., 1998; Steinert et al., 2015). These tissue-resident
memory T cells (TRM) are positioned at barrier tissues prone to
pathogenic invasion and are superior to circulating TEM cells in
protecting against local secondary infections.
A large proportion of CD8+ and CD4+ TRM cells expresses
specific signatures: CD4+ TRM cells identified in the lung co-
express CD11a and CD69 (Teijaro et al., 2011), whereas
CD8+ TRM cells co-expressing CD103 and CD69 have been
found in many tissues such as the skin, the brain, sensory
ganglia, the gut, and secretory glands (Gebhardt et al., 2009;
Kim et al., 1997; Klonowski et al., 2004; Pircher et al., 1990;
Scho¨n et al., 1999; Wakim et al., 2010). Secretory glands are
an attractive target tissue for viruses to persist in and exploit
mucosal secretions for dissemination. Human cytomegalovirus
(HCMV) is prevalent in 60%–90% of the world population and is
transmitted by prolonged shedding from infected mucosae
such as the salivary glands (SGs). Experimental infection of
mice with murine CMV (MCMV) has shown that CD8+ T cells
are able to control lytic virus infection in all organs with the
striking exception of the SG, owing to most-efficient virally
mediated MHC I downregulation in infected acinar glandular
epithelial cells (Lu et al., 2006). Instead, CD4+ T cells are
uniquely required to cease virus replication in the SG (Lucin
et al., 1992; Walton et al., 2011). This paradigm was based
on studies during primary CMV infection and suggests that
CD8+ T cells may also be incapable of curtailing viral reactiva-
tion or superinfection events during latency. Yet, the capacities
of CD8+ and CD4+ T cells to protect the SG from re-infection
and viral reactivation have not been evaluated.
Here, we address these questions by scrutinizing MCMV-
specific CD8+ and CD4+memory T cells in the SG for their migra-
tory potential, their maintenance, and their protective capacity
upon localized pathogen encounter. We found an exquisite
ability of the SG to induce both CD4+ and CD8+ TRM populations,
which are largely excluded from the circulation. Whereas CD8+
TRM induction was independent of local cognate antigen, CD4
+
TRM generation was strictly antigen dependent. CD103 expres-
sion in CD8+ T cells depended on TGFb, coincided with localiza-
tion of CD8+ T cells within glandular ducts, and supported the
establishment of a SG-resident CD8+ T cell population but wasorts 13, 1125–1136, November 10, 2015 ª2015 The Authors 1125
Figure 1. CD8+ and CD4+ T Cells in the
SG Express TRM Signatures upon MCMV
Infection
Naive Maxi CD8+ T cells and M25 CD4+ T cells
were adoptively transferred into naive recipients
followed by i.v. infection with 5 3 106 pfu MCMV.
(A and B) Representative flow cytometry contour
plots of Maxi (A) and M25 (B) TRM formation in
the SG, lung, and spleen at 8 wpi are shown.
(C and D) The percentage of Maxi (C) and M25
(D) cells with a TRM phenotype at 4, 8, and >20 wpi
is shown asmean + SEM of at least n = 10mice per
time point pooled from at least three independent
experiments. *p < 0.05 (unpaired two-tailed t test).
(E) Sections of SG tissue at 4 wpi were stained for
CD103 (orange), CD8/CD4 (green), EpCAM (red),
and DAPI (blue). The scale bars represent 20 mm.
(F) Statistical analysis of CD4+ and CD8+ T cell
localization in relation to EpCAM+ ducts. Data are
shown as mean + SEM of n = 4 mice from three
independent experiments. In total, the location of
638 CD8+ T cells and 1,069 CD4+ T cells was
determined. **p < 0.01; ***p < 0.001 (unpaired two-
tailed t test).
See also Figure S1.not required for its long-term maintenance. Functionally, using
intraglandular infection, we demonstrate that MCMV-specific
memory CD8+ T cells provide local protection, owing to initial
virus replication in non-epithelial cells that largely withstand
MCMV-mediated MHC I downregulation. Our findings establish
a role for MCMV-specific CD8+ T cells in the control of localized
SG infection.
RESULTS
CD8+ and CD4+ T Cells in the SGExpress TRM Signatures
upon MCMV Infection
TRM cells afford protection against local re-infection in a number
of infection models, prompting us to examine the SG’s potential
to form and maintain TRM cells specific for CMV, a virus that
persists in and spreads from this organ (Britt, 2007; Jonjic
et al., 1989).
To analyze the formation of TRM cells in the SG, we employed
an adoptive transfer approach using monoclonal Ly5.1+
TCR transgenic (TCRtg) CD8+ and CD4+ T cells, which are
specific for the immunodominant MCMV epitopes M38316–323
(Maxi CD8+ T cells; Torti et al., 2011) and M25411–425
(M25 CD4+ T cells; Jeitziner et al., 2013). Following systemic
MCMV infection, Maxi cells progressively upregulated CD69
and CD103, the signature markers of CD8+ TRM cells,1126 Cell Reports 13, 1125–1136, November 10, 2015 ª2015 The Authorsexclusively in the SG (Figures 1A and
1C). The majority of M25 cells in the
SG as well as a minor fraction in lung
and spleen co-expressed CD11a and
CD69 (Figures 1B and 1D), the signature
of CD4+ TRM cells (Teijaro et al., 2011).
Comparable patterns of CD103, CD69,
and CD11a expression were also ob-served in endogenous, non-transgenic CD8+ and CD4+
T cells (Figure S1).
With CD103 acting as a molecular tether to E-cadherin-
expressing epithelial cells (Cepek et al., 1994), we reasoned
that CD103+ CD8+ T cells would be selectively sequestered
to epithelia in the SG. We analyzed sections of infected
SG tissue by fluorescence microscopy and classified T cells
located within the borders of EpCAM-labeled SG ducts and
acini as intraepithelial (Figure 1E). The percentage of CD103+
cells localizing within epithelial ducts was significantly higher
compared to CD103 cells and CD4+ T cells (Figure 1F), indi-
cating a selective preference of CD103+ CD8+ T cells for intra-
epithelial localization.
CD103 Expression in CD8+ and CD69 Expression in
CD4+ Memory T Cells Identify Populations with
Restricted Circulatory Interchange
Disconnection from the circulation is a key feature of TRM cells
and clearly demarcates them from their circulating TEM or TCM
counterparts (Gebhardt et al., 2011). To confirm that T cells
with a TRM phenotype in the SG have limited access to the
circulation, we performed intravascular (i.v.) labeling using
fluorochrome-coupled antibodies (Anderson et al., 2014;
Teijaro et al., 2011). Whereas more than 97% of Maxi cells
were stained i.v.+ in the lung and spleen, over 80% of Maxi
Figure 2. CD103 Expression in CD8+ and CD69 Expression in CD4+ Memory T Cells Indicate Restricted Circulatory Interchange
(A and B) Mice were injected i.v. with anti-CD8-PE or anti-CD4-PerCP 3 min before sacrifice. Representative contour plots of i.v. labeling and TRM signature
expression of Maxi (A) and M25 (B) cells are shown.
(C–F) Mice were treated with BrdU in drinking water for 2 weeks starting the day of infection. BrdU dilution was analyzed at 8 wpi. Representative contour plots of
BrdU staining in Maxi (C) and M25 cells (E) are shown. Statistical analysis of %BrdU+ Maxi (D) and M25 (F) cells is shown.
Data are shown as mean + SEM of n = 5 mice from one experiment. Dotted line indicates BrdU+ fraction of Maxi or M25 in blood. DN, CD103 CD69 double
negative; DP, CD103 CD69 double positive; ns, not significant; *p < 0.05; ***p < 0.001 (unpaired two-tailed t test). See also Figure S2.cells in the SG were spared from i.v. labeling (i.v.; Figure 2A,
top). The majority of SG-isolated i.v. Maxi cells expressed
CD103 (Figure 2A, bottom). Similarly, the majority of M25 cells
was spared from i.v. labeling in the SG (Figure 2B, top),
coinciding with pronounced expression of the CD4+ TRM signa-
ture (Figure 2B, bottom). These results were not due to insuffi-
cient antibody transfer to the SG, as i.v. labeling of CD31+
endothelial cells was equally effective in the SG and the lung
(Figure S2).
To gain further insight into the exchange of SG and circu-
lating T cell compartments, we treated mice with BrdU for
2 weeks starting the day of infection, thus labeling all prolifer-Cell Repating cells including TRM cells that are seeded to the SG.
A hallmark of CMV infection is the continuous proliferation of
effector T cells with certain specificities (termed ‘‘memory
inflation’’; Karrer et al., 2003; Munks et al., 2006), yielding a
growing population of circulating BrdU CD8+ TEM cells, which
will consequently dilute circulating BrdU+ T cells after discon-
tinuation of BrdU administration. We hypothesized that
TRM cells will maintain a high BrdU
+ fraction as a result of
restricted circulatory exchange. Indeed, at 8 wpi, BrdU+ Maxi
cells were strongly diluted in blood, lung, and spleen (Figures
2C and 2D). In contrast, the majority of Maxi cells in the SG
remained BrdU+, indicating that their circulatory exchangeorts 13, 1125–1136, November 10, 2015 ª2015 The Authors 1127
Figure 3. Local CognateAntigen IsRequired
for CD4+, but Not CD8+, TRM Formation and
Maintenance
(A) Experimental setup for the generation of three
different settings of antigen availability. (1) M25
and Maxi cells were adoptively co-transferred into
C57BL/6 recipients with subsequent MCMV
infection (53 106 pfu) to provide antigen in the SG
and spleen. (2) Smarta and P14 cells were adop-
tively co-transferred into C57BL/6 mice with sub-
sequent LCMV-WE infection (200 ffu) to provide
antigen in the spleen, but not in the SG. (3) M25 and
Maxi cells were adoptively co-transferred prior to
MCMV infection. At 1 wpi, CD4+ and CD8+ sple-
nocytes were isolated by MACS and transferred
into naive recipients with no cognate antigen in the
SG and spleen.
(B) CD4+ and CD8+ TRM formation at 4 weeks post-
cell transfer is shown as mean + SEM of at least
n = 10 mice pooled from two independent experi-
ments.
(C) Micewere infected i.v. with 106 ffu LCMVDocile
or 200 ffu LCMV-WE. Viral titers in the SG were
determined at 8 wpi.
(D and E) Representative contour plots (left) and
statistical analysis (right) of gp33-tet+ CD8+ T cells
8 wpi (D) or Smarta CD4+ T cells 4 wpi (E) with
200 ffu LCMV-WE or 106 ffu LCMV Docile are
shown as mean + SEM of n = 5 mice from one
experiment.
(F) Experimental setup: in-vivo-activated spleen-
derived M25 cells were transferred into naive
mice, mice infected for 3 weeks with LCMV
Docile, mice infected for 3 weeks with MCMV,
or naive mice that received the M25 peptide
via the excretory duct of the SG at the day of
transfer.
(G) Total M25 cells with a TRM phenotype at
4 weeks posttransfer. Transfer to naive: n =
15 mice; transfer to Docile infected: n = 6 mice; transfer to MCMV infected: n = 8 mice; transfer to mice that received peptide: n = 2 mice.
In (B)–(G), *p < 0.05; **p < 0.01; ***p < 0.001 (unpaired two-tailed t test). See also Figure S3.was significantly limited. Among Maxi cells in the SG, the
CD103+ CD69+ subset retained the largest BrdU+ fraction
(Figure 2D), suggesting CD103 as a marker of CD8+ T cells
with restricted recirculation. M25 T cells do not inflate, resulting
in higher BrdU+ frequencies in circulating compartments (Fig-
ures 2E and 2F). Nevertheless, M25 cells in the SG retained
significantly higher proportions of BrdU+ cells compared to
blood, and CD69+ M25 cells in all compartments maintained
a higher BrdU+ fraction than their CD69 counterparts. As an
alternative explanation, the BrdU disequilibrium might have
been caused by differences in organ-specific cell division rates,
i.e., T cells in the SG might divide less rapidly than in the lung,
thus retaining a larger BrdU fraction. However, if circulatory
exchange was possible, one would assume that the resulting
discrepancy in BrdU levels would equilibrate between these
compartments.
Taken together, these data indicate that MCMV infection
results in substantial formation of MCMV-specific SG-resident
CD8+ and CD4+ TRM cell populations that express TRM signa-
tures, show restricted vascular accessibility, and are largely
disconnected from circulatory interchange.1128 Cell Reports 13, 1125–1136, November 10, 2015 ª2015 The AuLocal Cognate Antigen Is Required for CD4+, but Not
CD8+, TRM Formation and Maintenance
The presence of both CD8+ and CD4+ TRM cells within the same
organ allowed us to directly compare the requirements for their
recruitment, retention, and TRM phenotype induction. Previous
studies indicate that the tissue of residence dictates whether
local antigen is required for CD8+ TRM formation (reviewed in
Gebhardt and Mackay, 2012). We assessed the requirement of
cognate antigen for TRM formation in the SG by three experi-
mental setups with varying local and systemic, i.e., splenic,
antigen availability (Figure 3A). To create a situation providing
cognate antigen in the spleen and locally in the SG, we adop-
tively transferred M25 or Maxi T cells and subsequently infected
mice with MCMV (Figure 3A, panel 1). To provide antigen in the
spleen, but not in the SG, LCMV-specific TCRtg Smarta CD4+
T cells and P14 CD8+ T cells were transferred with subsequent
low-dose LCMV-WE infection (Figure 3A, panel 2), which does
not lead to SG infection (Hofmann and Pircher, 2011). To eval-
uate TRM induction in absence of systemic and local SG antigen,
we transferred purified, previously in vivo MCMV-activated
Maxi and M25 cells into naive recipients (Figure 3A, panel 3).thors
Figure 4. TGFb Is Required for Induction of
CD103, but Not CD69, Expression
Tgfbr2f/f dLck-Cre+ mice and Tgfbr2f/f dLck-Cre
littermates were infected i.v. with 5 3 106 pfu
MCMV, and M38-specific cells were tracked by
tetramer staining at 4 wpi.
(A) Representative contour plots of M38-tet+ cells
are shown.
(B) Percentages of M38-tet+ cells expressing
CD103 and CD69 are shown as mean + SEM of
n = 10 mice pooled from two independent experi-
ments.
(C) Viral titers of SG tissue at 4 wpi.
(D) Total numbers of M38-specific CD8+ T cells are
shown as mean + SEM of n = 10 mice pooled from
two independent experiments.
*p < 0.05; **p < 0.01; ***p < 0.001 (unpaired two-
tailed t test). See also Figure S4.Restriction of systemic and local antigen negatively affected TRM
formation in CD4+, but not in CD8+, TCRtg T cells at 4 weeks
posttransfer (Figure 3B), correlating with total T cell numbers in
the SG: whereas both CD4+ and CD8+ TCRtg T cells were
detectable at 4 weeks posttransfer regardless of whether anti-
gen was present, CD4+, but not CD8+, TCRtg T cells were strik-
ingly reduced at 8 weeks posttransfer, and the magnitude of
reduction correlated with the deprivation of antigen (Figure S3).
Previously published data suggest that sustained antigen pres-
ence prevents CD8+ TRM differentiation in the gut (Casey et al.,
2012). We analyzed the phenotype of LCMV-specific CD8+
T cells in the SG after chronic infectionwith LCMVDocile, leading
to pronounced LCMV replication in the SG (Figure 3C). We found
that CD8+ T cells were significantly impaired in CD103 expres-
sion during chronic LCMV Docile compared to resolved LCMV-
WE infection (Figure 3D), supporting a negative impact of
persistent antigen on CD8+ TRM formation in the SG. In line
with our hypothesis that presence of cognate antigen enables
CD4+ TRM formation, TRM signature expression in Smarta CD4
+
T cells was significantly enhanced in chronically infected mice
(Figure 3E).
Our data clearly indicate that CD8+ TRM formation is indepen-
dent of both antigen and inflammation. Next, we analyzed
whether CD4+ TRM formation relied on cognate antigen or
whether unspecific inflammation was sufficient to induce CD4+
TRM cells in the SG. We transferred in-vivo-activated, spleen-
derived M25 CD4+ T cells into mice that had been infected for
3 weeks with LCMV Docile (virus replication in the SG and other
organs; no cognate antigen) or mice that had been infected with
MCMV for 3 weeks (virus replication only in the SG, but not in
other organs) and naive mice that received the M25 peptide via
the excretory duct of the SG at the day of transfer (Figure 3F).Cell Reports 13, 1125–1136, NoWe found that the abundance ofM25 cells
with a TRM phenotype was significantly
elevated only when cognate antigen was
present (Figure 3G).
Taken together, these data show that,
whereas both CD8+ and CD4+ T cells
can migrate to the SG independently ofcognate antigen, only CD4+ T cells require local antigen for
tissue maintenance and TRM formation.
TGFb Is Required for Induction of CD103, but Not CD69,
Expression
TGFb is a known inducer of CD103 in CD8+ T cells in various
experimental systems (Casey et al., 2012; El-Asady et al.,
2005; Lee et al., 2011). We analyzed the endogenous MCMV
M38-specific CD8+ T cell response in mice exhibiting a T-cell-
specific deletion of the TGFbRII (Tgfbr2f/f dLck-Cre mice; Zhang
and Bevan, 2013). At 4 wpi, M38-specific CD8+ T cells in the SG
were severely impaired in CD103 and CD69 co-expression in
contrast to Cre littermates (Figures 4A and 4B) whereas viral
titers were comparable in both mouse strains (Figure 4C).
Whereas CD103 expression in CD8+ T cells was completely
dependent on TGFb, CD69 expression was not. Tgfbr2f/f
dLck-Cre mice showed a significant reduction of the M38-
specific CD8+ T cell pool in the SG, reaching a 5.73 reduction
compared to Cre controls at 4 wpi (Figure 4D). This reduction
could not only be explained by the absence of the CD103+
fraction, as the CD69+ and CD69CD103 M38-specific CD8+
T cell populations were also strikingly reduced. Hence, besides
being essential for CD103 induction in CD8+ T cells in the
SG, TGFb also promotes the size of the SG-resident CD8+
T cell population by additional, CD103-unrelated mechanisms.
Consistent with the CD8+ T cells, CD4+ T cells in the SG of
Tgfbr2f/f dLck-Cre mice were not restricted in CD69 expression;
neither were they affected to express high levels of CD11a, and
the size of the endogenous CD4+ TRM population was unaffected
(Figure S4A). The dependence of CD103 expression on TGFb in
the SG was confirmed using mice expressing a T-cell-specific
dominant-negative variant of the TGFbRII (Gorelik and Flavell,vember 10, 2015 ª2015 The Authors 1129
Figure 5. CD103 Promotes Initial Establishment, but Not Long-Term Maintenance, of CD8+ TRM Cells
(A) Experimental setup. CD103/ Maxi and WT Maxi cells were transferred separately into C57BL/6 hosts with subsequent MCMV infection.
(B) Total numbers of CD103/ and WT Maxi cells are shown as mean + SEM of n = 10 mice pooled from two independent experiments.
(C) Experimental setup. CD103/ Maxi and WT Maxi cells were transferred, and recipients were infected as in (A). Mice were treated with 5 mg/ml FTY720 in
drinking water starting 1 wpi.
(D) Percentages of CD103/ and WT Maxi in blood and total cell numbers in SG and spleen are shown as mean + SEM of n = 10 mice pooled from two
independent experiments.
(E) Representative contour plots of CCR7/ Mini and WT Mini cells in SGs of C57BL/6 recipients at 4 and 8 wpi are shown.
(F) Statistical analyses of TRM markers at 4 and 8 wpi in CCR7
/ Mini and WT Mini cells are shown as mean + SEM of n = 5 mice from one experiment.
(G) MFI of Bcl-2 expression in CD103+ and CD103 Maxi cells in the SG at 8 wpi is shown as mean + SEM of n = 5 mice representative of three independent
experiments.
In (B), (D), (F), and (G), *p < 0.05; **p < 0.01; ***p < 0.001 (unpaired two-tailed t test).2000; Figure S4B). IL-15 was previously identified as an inducer
of CD103 in CD8+ TRM cells in the skin (Mackay et al., 2013). By
transferring in-vivo-activated Maxi cells into naive IL-15/
recipients, we demonstrate that CD103 and CD69 co-expres-
sion was not compromised in the SG in absence of IL-15 (Fig-
ure S4C). Apart from TCR stimulation, IFNa induces CD69
expression in T cells (Shiow et al., 2006). We co-transferred
wild-type (WT) P14 cells and P14 cells that lack the IFNa receptor
(IFNAR/ P14) into naive hosts followed by infection with
recombinant Vaccinia virus expressing the glycoprotein of
LCMV (VV-G2) and found that both IFNAR/ P14 as well
as WT P14 were not compromised in CD8+ TRM formation
(Figure S4D).
Taken together, these data indicate that CD8+ T cells in the SG
depend on TGFb for CD103 expression, TGFb additionally exerts1130 Cell Reports 13, 1125–1136, November 10, 2015 ª2015 The Aua CD103-independent role in the establishment of a MCMV-
specific CD8+ T cell population, and IL-15 does not promote
CD103 upregulation in the SG.
CD103 Promotes Initial Establishment, but Not Long-
Term Maintenance, of CD8+ TRM Cells
CD103 supports T cell retention in tissues by tethering CD8+
T cells to epithelial cells via interaction with E-cadherin (Cepek
et al., 1994) and upregulation of the anti-apoptotic molecule
Bcl-2 (Mackay et al., 2013). To investigate whether CD103+
CD8+ T cells in the SG benefit from thesemechanisms, we trans-
ferred CD103-deficient Maxi cells (CD103/Maxi) into C57BL/6
recipients and compared their abundance with WT Maxi in the
SG following MCMV infection (Figure 5A). We found that both
cell populations were equally well established and maintainedthors
in the SG and spleen (Figure 5B).MCMV-derived antigen presen-
tation in lymph nodes (LNs) reactivates local CD8+ TCM cells,
which subsequently migrate to peripheral tissues to contribute
to a constant effector CD8+ T cell pool (Torti et al., 2011). A small
proportion of these reactivated CD8+ T cells also gains access to
the SG, as demonstrated by the presence of BrdU cells in the
SG at 8 wpi (Figures 2C and 2D). We therefore investigated
whether continuous recruitment of new effector CD8+ T cells
renders CD103 dispensable for the preservation of the CD8+
TRM population in the SG. We restricted reseeding to the SG
from LNs by abrogating LN egress of T cells via FTY720 treat-
ment starting at 1 wpi (Figure 5C). Despite their ability to expand
to equal levels in the blood at 1 wpi and to maintain their popu-
lation in the spleen at 4 wpi, CD103/Maxi cells were markedly
reduced compared to WT Maxi in the SG (Figure 5D). At 8 wpi,
this deficit was still evident in the SG; however, total numbers
of CD103/ Maxi cells remained constant, indicating that
CD103 is not required for long-term maintenance but can
support the initial establishment of the SG-resident Maxi popula-
tion. However, this supportive function of CD103 is dispensable
when LN resupply is available.
The reduced numbers of CD103/ CD8+ T cells in the SG
could either be due to a survival deficit or due to selective egress
of CD103CD8+ T cells from the SG. To investigate the latter op-
tion,we transferredand trackedMCMV-specificCD8+T cells that
lackCCR7, a receptor required for egress fromperipheral tissues
(Bromley et al., 2005; Debes et al., 2004) as well as for T cell entry
into LNs (Fo¨rster et al., 1999). Being incapable of tissue emigra-
tion, CCR7/ CD8+ T cells are trapped in the respective organ.
Furthermore, CCR7/ CD8+ T cells are incapable of entering
LNs, thus their seeding to theperiphery relies solely on the spleen.
CCR7/ CD8+ T cells in the SG were strongly skewed toward
a TRM phenotype, with CD103
 cells being essentially absent by
8 wpi (Figures 5E and 5F), indicating that the reduction of
CD103 cells is not a result of selective tissue emigration but
rather of a survival deficit. In line with this hypothesis, CD103+
Maxi cells expressed significantly elevated levels of the anti-
apoptotic molecule Bcl-2 compared to CD103 Maxi cells (Fig-
ure 5G). Taken together, these data suggest that CD103 can
fulfill the previously described functions to support the mainte-
nance of SG-resident CD8+ T cells; however, its role becomes
dispensable in the context of CMV infection due to continuous
resupply of CD8+ T cells.
CD8+ T Cells Have Protective Capacity upon Local
Infection
CD8+ T cells are sufficient to control lytic MCMV replication in all
organs except the SG, where MCMV-mediated MHC I downre-
gulation in infected acinar glandular epithelial cells renders
CD8+ T cells inoperative and CD4+ T cells are required for viral
control (Jonjic et al., 1989; Walton et al., 2011). Whether CD4+
T cells are also responsible to control viral reactivation or re-
infection events is not known. To investigate this, we introduced
virus via intraglandular (i.g.) injection (Pilgrim et al., 2007). Infec-
tion of one of the two submandibular SG lobes with 104 pfu
MCMV resulted in confined virus replication to the injected
lobe during the first 11 days postinjection (Figure 6A), validating
this method to study the control of localized infection. We lodgedCell Repin-vivo-activated Maxi or M25 cells in the SGs of naive recipients
for 5 weeks and determined whether their presence affected
virus titers at 4 days post-i.g. infection (Figure 6B, left). More
than 70% of mice harboring T Maxi cells could completely con-
trol i.g.-administered virus, as opposed to mice that did not
receive T cells via adoptive transfer or had received M25 cells
(Figure 6B, right). Maxi cells located in the SG were readily
capable to exert effector functions, as judged by the expression
of IFNg and the degranulation marker CD107a (Figures 6C
and 6D). These data suggest that, despite their restricted
potency to control primary systemic infection, memory CD8+ T
cells in the SG can control locally introduced MCMV.
Cells Targeted by Local Infection Withstand Complete
CMV-Mediated MHC I Downregulation
CMV-mediated MHC I downregulation in the SG substantially
contributes to the inability of CD8+ T cells to control virus replica-
tion (Luet al., 2006;Walton et al., 2011). Tounderstandwhymem-
oryMaxi T cellswere able to control local infection, we character-
ized the early cell types targeted by i.g. injection. We visualized
infected cells using a GFP expressing MCMV strain (MCMV-
GFP). Cells infected by i.g. injection extended dendrites and
were arranged in a network (Figures 7A and 7B), reminiscent of
the previously described macrophage network in the SG (Thom
et al., 2014). This morphology differed substantially from that of
infected acinar glandular epithelial cells, the cell type of viral
persistence (Figures 7C and 7D) at 2 wpi, suggesting that the vi-
rus initially replicates in cells of non-epithelial origin before occu-
pying its niche of persistence. At 4 days post-i.g. infection, both
hematopoietic and non-hematopoietic cells were infected and
a fraction of the hematopoietic targets expressed CD11c, indic-
ative of SG-resident APCs (Figures 7E and 7F). Infected non-
hematopoietic cells were not EpCAM+, confirming that epithelial
cells are not the primary target of locally introduced MCMV (Fig-
ure 7G). Despite a detectable onset of MHC I downregulation,
MHC I was abundant in infected non-hematopoietic (Figure 7G)
and hematopoietic cells (Figure 7H), indicating that cells targeted
early by i.g. infection largely resist virally mediated MHC I down-
regulation—at least up to 4 dpi. Thus, early local re-infection pro-
vides a window of opportunity for readily positioned CD8+ TRM
cells to recognize infected cells and control virus replication
despite the presence of viral immune evasion genes. In contrast
to the abundance of MHC I molecules, MHC II expression was
rare and confined to a minority of CD11c+ hematopoietic targets
(Figure 7H), providing an explanation why CD8+ T cells were
superior in controlling i.g. infection compared to CD4+ T cells.
DISCUSSION
CMV infection leads to protracted infection of the SG, fostering
horizontal virus transmission inmice and humans. Our data high-
light the SG’s exquisite capacity to instruct and lodge CD8+ and
CD4+ TRM cells followingMCMV infection.Whereas bothMCMV-
specific CD4+ and CD8+ TRM cells were maintained long term in
the SG after control of lytic replication, the requirements for their
local induction, their micro-anatomical localization, and their
protective capacities in localized infection events differed
substantially.orts 13, 1125–1136, November 10, 2015 ª2015 The Authors 1131
Figure 6. CD8+ T Cells Have Protective Capacity upon Local Infection
(A) Virus kinetics after i.g. infection of one SG lobe with 104 pfu MCMV (input). Data are shown as mean ± SEM of n = 4 mice for each time point. LOD, limit of
detection.
(B) Experimental design to assess the protective capacity of Maxi and M25 cells (left). Maxi and M25 cells were adoptively transferred into C57BL/6 recipients
followed by MCMV infection. At 1 wpi, CD8+ and CD4+ T cells were isolated from spleens by MACS purification and injected into naive recipients. After 5 weeks,
recipients were infected i.g. with 104 pfu MCMV to both SG lobes and virus titers were determined 4 days later. Percentage of controllers and non-controllers at
4 days after i.g. MCMV infection is shown (right). Results are pooled data from at least n = 10 mice per group from three independent experiments. *p < 0.05
(Fisher’s exact test).
(C and D) T cells from SG and lung tissue were restimulated with M38 peptide. (C) Representative contour plots gated on Maxi cells showing IFNg and CD107a
staining are shown. (D) Statistical analysis of IFNg and CD107a staining upon restimulation is shown as mean + SEM of n = 5 mice, representative of two in-
dependent experiments.Previous studies indicate that the necessity of local antigen for
TRM formation is largely dictated by the organ of residence.
Whereas antigen-independent CD8+ TRM induction is supported
in the gut, the skin, the female reproductive tract, as well as in the
SG upon LCMV infection (Casey et al., 2012; Hofmann and
Pircher, 2011; Mackay et al., 2012), CD8+ TRM cell formation in
the brain requires local antigen (Wakim et al., 2010). We show
here that, in contrast to CD4+ T cells, local antigen is dispensable
for TRM induction in MCMV-specific CD8
+ T cells in the SG, indi-
cating that T cell subset-specific demands are different and
outweigh organ-specific effects. Previous data indicate that
lung-resident CD4+ T cells acquire TRM signatures independently
of local cognate antigen (Teijaro et al., 2011), suggesting that the
necessity of antigen for CD4+ TRM development depends on the
tissue of residence.
Cytokines play a critical role in TRM development. The expres-
sion of CD103 and CD69 phenotypically characterizes a major1132 Cell Reports 13, 1125–1136, November 10, 2015 ª2015 The Auproportion of CD8+ TRM cells, and TGFb is an instructive signal
for CD103 expression. We confirm that this is also the case for
MCMV-specific CD8+ TRM cells forming after MCMV infection
in the SG. In line with our results, MCMV-specific T cells upregu-
lated CD103 in response to TGFb stimulation in vitro and MCMV
infection did not increase levels of TGFb protein in the SG,
providing an explanation why the naive SG supports CD103
upregulation equally well as the MCMV-infected SG (Smith
et al., 2015, this issue of Cell Reports). As IL-15 was recently
shown to induce CD103 expression in HSV-specific CD8+
T cells in the skin (Mackay et al., 2013), we assessed its role
for CD8+ TRM induction in the SG but found no evidence for an
involvement. Themechanisms leading to constitutive expression
of CD69 on TRM cells remain unclear. The reduced CD69 expres-
sion in CD8+ TRM cells in the gut of Tgfbr2
f/f dLck-Cre mice sug-
gested a role for TGFb in CD69 upregulation (Zhang and Bevan,
2013). Our data show that neither MCMV-specific CD8+ northors
Figure 7. Cells Targeted by Local Infection
Withstand to Complete CMV-Mediated
MHC I Downregulation
(A and B) Sections of SG tissue at 4 days post-i.g.
infection with 5 3 105 pfu MCMV-GFP represen-
tative of n = 3 mice. The scale bar represents
50 mm (A) and 20 mm (B).
(C) Section of SG tissue at 3 weeks post-i.v.
infection with 5 3 106 pfu MCMV-GFP represen-
tative of n=3mice. The scale bar represents 50mm.
(D) Section of SG tissue at 2 weeks post-i.g.
infection with 5 3 105 pfu MCMV-GFP represen-
tative of n = 3 mice. The scale bar represents
20 mm.
(E–H) Flow cytometry analysis of SG isolated cells
targeted by MCMV-GFP at 4 days post-i.g. infec-
tion. Infected cells were distinguished from non-
infected cells by GFP expression. Results are
representative of three independent experiments.
(E) Representative contour plot of GFP+ cells
showing CD45 and CD11c expression is shown.
(F) Statistical analysis of cell types infected after
i.g. MCMV-GFP infection is shown. Shown are
means + SEM of n = 3 mice from one experiment.
(G) Representative histogram and contour plot of
EpCAM, MHC I, and MHC II expression of non-
hematopoietic (CD45) GFP+ cells are shown.
(H) Representative contour plots of MHC I and
MHC II expression of hematopoietic (CD45+) GFP+
cells are shown.CD4+ TRM cells in the SG required TGFb signaling for CD69
expression. Type I interferons are also known to induce CD69
expression (Shiow et al., 2006), but type I interferon receptor
signaling was not required for the sustained expression of
CD69 on MCMV-specific TRM cells in the SG.
In many cases, CD103 plays a central role in CD8+ TRM cell
maintenance through two mechanisms: CD103 promotes
T cell survival by upregulation of the anti-apoptotic molecule
Bcl-2 (Mackay et al., 2013; Wakim et al., 2010) and exerts
adhesive function by tethering T cells to E-cadherin (Cepek
et al., 1994). Mechanistically, CD103+ CD8+ TRM cells in the
SG appear to profit from both mechanisms, indicated by
elevated levels of Bcl-2 as well as preferential localization
within epithelial ducts compared to CD103 CD8+ T cells and
CD4+ T cells. However, in light of constant resupply by reacti-
vated CD8+ memory T cells from LNs (Torti et al., 2011) and
vascular sources (Smith et al., 2014), CD103 is functionally
dispensable in the SG. These data suggest that the importance
of CD103 for CD8+ TRM maintenance might be dictated by the
nature of infection. Most CD4+ TRM cells do not express
CD103, excluding a function in CD4+ TRM maintenance. It re-
mains to be determined whether CD4+ TRM retention is
achieved by CD69 through its inhibitory effect on cell surface
expression of the sphingosine-1-phosphate receptor 1 (S1P1),
which is required for T cell egress from organs (Bankovich
et al., 2010; Matloubian et al., 2004).
The fact that MCMV infection promotes the establishment of
considerable populations of both MCMV-specific CD4+ and
CD8+ TRM cells specifically in the SG suggests that the stra-
tegic positioning of these cells at relevant re-entry sites of theCell Repvirus affords immediate local protection and hence curtails hor-
izontal transmission upon re-infection. During primary MCMV
infection, CD4+ T cells are the only cell type capable of control-
ling lytic infection in the SG (Jonjic et al., 1989). The inability of
CD8+ T cells to control lytic MCMV replication in the SG upon
primary infection is due to the profound virally mediated down-
regulation of MHC I expression on the main long-term target
cells of MCMV, the acinar glandular epithelial cells (Walton
et al., 2011). We therefore hypothesized that MCMV-specific
CD8+ TRM cells would also be incapable of controlling local
re-infection events. Contrary to our expectations, memory
CD8+ T cells were superior in providing local protection
compared to memory CD4+ T cells. Detailed analysis of the
cell types permissive for MCMV infection and replication at
early time points in the SG revealed that MCMV targeted largely
non-epithelial cells and, to a lesser extent, hematopoietic cells
including tissue macrophages. MCMV failed to achieve com-
plete MHC I downregulation in these early SG target cells,
thereby providing a window of opportunity for CD8+ TRM cells
to detect viral antigen and control virus replication. Thus, the
potential of CD8+ TRM cells to confer immediate protection
against localized SG infection illustrates that the effort of the
SG in hosting a sizeable population of CD8+ TRM cells indeed
has physiological advantages that are explained by the altered
composition of MCMV-targeted cell types at early time points
of localized infection.
So far, CMV superinfection studies were mainly conducted
using the subcutaneous route of re-infection, which is likely lead-
ing to a systemic viral challenge (Bo¨hm et al., 2008; Hansen et al.,
2010; Holtappels et al., 2008; Reddehase et al., 1987). Systemicorts 13, 1125–1136, November 10, 2015 ª2015 The Authors 1133
memory CD8+ T cells were shown to protect against lethal chal-
lenge in immunocompromised murine hosts (Bo¨hm et al., 2008;
Holtappels et al., 2008) or to provide protection against systemic
reactivation of CMV in immune-suppressed organ transplant
recipients (Bunde et al., 2005; Nauerth et al., 2013; Scheinberg
et al., 2009). Furthermore, expression of CMV-encoded immune
evasion genes led to the inability of CMV-specific CD8+ T cells to
restrict subcutaneous CMV superinfection (Nauerth et al., 2013).
Here, we show that CMV-encoded immune evasion genes do
not compromise the ability of CD8+ memory T cells in protecting
against re-infection with CMV.
In summary, we delineate the extraordinary capacity and the
mechanisms by which the SG accommodates TRM memory
cells in an epidemiologically relevant infection model and
demonstrate the protective capacity of memory CD8+ T cells
upon localized MCMV infection of the SG, highlighting a yet-
unappreciated role of CD8+ T cells in this organ. The mech-
anisms by which SG CD8+ TRM cells can mediate this immunity
may involve direct cytotoxicity and effector cytokine production
or the establishment of a broad, organ-wide antiviral state,
such as shown for CD8+ TRM cells in the female repro-




This study was conducted in accordance to the guidelines of the animal exper-
imentation law (SR 455.163; TVV) of the Swiss Federal Government. The pro-
tocols were approved by the Cantonal Veterinary Office of the canton Zurich,
Switzerland (permit number 109/2011, 110/2011, 127/2011).
Mice
All mice were housed and bred (C57BL/6 mice, CCR7/ mice [Fo¨rster et al.,
1999], and CD11c-YFP reporter mice [Lindquist et al., 2004]) in SPF facilities.
IL15/ mice (Kennedy et al., 2000) were provided by Prof. O. Boyman
(University Hospital of Zurich). DnTGFbRII mice (Gorelik and Flavell, 2000)
were provided by Dr. J. Herkel (Universitaetsklinikum Hamburg-Eppendorf).
Tgfbr2f/f dLck-Cre mice (Zhang and Bevan, 2012) were a gift of Prof.
M. Bevan (University of Washington). Maxi transgenic (Ly5.1+) mice express
a TCR specific for the MCMV peptide M38316–323 (Torti et al., 2011) M25
transgenic (Ly5.1+) mice express a TCR specific for the MCMV peptide
M25410–425 (Mandaric et al., 2012). P14 transgenic (Ly5.1
+) mice express a
TCR specific for the LCMV peptide gp33–41 (Pircher et al., 1990). Smarta
transgenic (Ly5.1+) mice express a TCR specific for the LCMV peptide
gp61–80 (Oxenius et al., 1998).
Viruses and Infections
Recombinant MCMV deficient in m157 (MCMV-Dm157) was previously
described (Walton et al., 2008) and is referred to as MCMV in this study.
The MCMV mutant expressing GFP under the m157 promoter was described
in Hasan et al. (2005). MCMV strains were propagated on MEFs as described
(Brune et al., 2001). Virus titers of organs were determined on M2-10B4 cells
as described recently (Zurbach et al., 2014). For systemic infection, mice
were infected intravenously with 5 3 106 pfu MCMV-Dm157. Focused
i.g. infection was performed with modifications as previously described
(Pilgrim et al., 2007; see Supplemental Experimental Procedures). The
LCMV isolate WE and Docile were provided by Dr. R.M. Zinkernagel (Univer-
sity Hospital) and propagated at a low MOI on L929 fibroblast cells. Mice
were intravenously infected with 200 ffu LCMV-WE for low-dose infection
and 106 ffu LCMV Docile for chronic infection. Recombinant Vaccinia virus
expressing the LCMV glycoprotein (VV-G2) was originally obtained from
Dr. D.H.L. Bishop (Oxford University) and was grown on BSC40 cells1134 Cell Reports 13, 1125–1136, November 10, 2015 ª2015 The Auat low MOI. Infection of VV-G2 was performed by intraperitoneal injection
of 5 3 106 pfu VV-G2.
Adoptive Transfer
CD8+ and CD4+ T cells were isolated from naive Maxi, CD103/ Maxi, P14,
M25, Smarta (all Ly5.1+), or INFAR/ P14 (Thy1.1+) mice using magnetic
anti-CD8 or anti-CD4 beads (Miltenyi Biotech). 106 M25 cells or 104 of all other
transgenic cells were adoptively transferred into naive recipient mice 1 day
prior to infection. To study the migration and maintenance of in-vivo-activated
T cells, splenocytes were isolated 1 wpi and 106 T cells purified byMACSwere
transferred into naive recipient mice. To study themaintenance of CD8+ T cells
in the SG, mice were treated with 5 mg/ml FTY720 (US Biological) in the drink-
ing water, starting 1 wpi.
Lymphocyte Isolation, i.v., Intracellular, and Cell Surface Staining
Lymphocytes were isolated from spleen and SG as previously described
(Joller et al., 2007), with the modification that cell suspensions were not
subjected to a Percoll gradient. Staining for flow cytometry was performed
on whole-blood or single-cell suspensions from the indicated organs as
described in the Supplemental Experimental Procedures. Data were
acquired on a LSRII flow cytometer (BDBioscience) and analyzed using Flowjo
software (Treestar).
Statistical Analysis
Statistical significance was determined as indicated either by two-tailed
unpaired t test or Fisher’s exact test using GraphPad Prism.
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